Nu-Med Plus, Inc. engages in the design, development, and marketing of technologies utilizing nitric oxide in the medical device field. The company is headquartered in Salt Lake City, Utah and currently employs 2 full-time employees. The company went IPO on 2013-08-02. The company focuses on the creation of a nitric oxide (NO) generating formulation, a hospital bedside NO delivery system, a clinical unit for use in medical clinics and rehabilitation centers and a mobile rechargeable device to deliver nitric oxide gas to offer solutions to hospitals, health systems and the medical community throughout the world. Hospital NO Unit delivers a continuous intra-breath concentration of therapeutic NO to patients who are on a ventilator in a hospital setting. The Clinical Delivery System is a simplified version of the hospital unit. Portable Delivery System delivers NO to the patient at prescribed intervals for 24 hours per day at controlled doses by means of a nasal cannula or a face mask. Reagent Delivery offers a range of concentrations and flow rates of NO.
How did NUMD's recent EPS compare to expectations?
The most recent EPS for Nu-Med Plus Inc is $, expectations of $.
How did Nu-Med Plus Inc NUMD's revenue perform in the last quarter?
Nu-Med Plus Inc revenue for the last quarter is $
What is the revenue estimate for Nu-Med Plus Inc?
According to of Wall street analyst, the revenue estimate of Nu-Med Plus Inc range from $ to $
What's the earning quality score for Nu-Med Plus Inc?
Nu-Med Plus Inc has a earning quality score of B/38.841022. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Nu-Med Plus Inc report earnings?
Nu-Med Plus Inc next earnings report is expected in 2026-07-14
What are Nu-Med Plus Inc's expected earnings?
Nu-Med Plus Inc expected earnings is $, according to wall-street analysts.
Did Nu-Med Plus Inc beat earnings expectations?
Nu-Med Plus Inc recent earnings of $ expectations.